Companies: 10,795     total market cap: S$182.686 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ
Exelixis
EXEL
#1812
Rank
S$14.96 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
S$57.63
Share price
3.92%
Change (1 day)
24.09%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : S$0.86 Billion

According to Exelixis's latest financial reports the company's total liabilities are S$0.86 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exelixis - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31S$0.87 B-8.28%
2024-12-31S$0.95 B6.72%
2023-12-31S$0.89 B14.63%
2022-12-31S$0.78 B42.54%
2021-12-31S$0.54 B60.52%
2020-12-31S$0.34 B26.88%
2019-12-31S$0.26 B46.16%
2018-12-31S$0.18 B-62.81%
2017-12-31S$0.49 B-32.42%
2016-12-31S$0.73 B9.51%
2015-12-31S$0.66 B15.62%
2014-12-31S$0.57 B4.54%
2013-12-31S$0.55 B6.63%
2012-12-31S$0.51 B32.51%
2011-12-31S$0.39 B-48.35%
2010-12-31S$0.75 B6.59%
2009-12-31S$0.71 B8.73%
2008-12-31S$0.65 B39.33%
2007-12-31S$0.46 B0.56%
2006-12-31S$0.46 B1.92%
2005-12-31S$0.45 B16.8%
2004-12-31S$0.39 B17.72%
2003-12-31S$0.33 B17.79%
2002-12-31S$0.28 B39.83%
2001-12-31S$0.20 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
S$149.63 B 17,125.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$154.36 B 17,669.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$104.19 B 11,893.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$82.30 B 9,374.65%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$107.08 B 12,226.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$90.96 B 10,371.61%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$77.34 B 8,803.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
S$53.83 M-93.80%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
S$92.05 M-89.40%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com